Search Results

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients.

• Authors : Francke, M. I.; Visser, W. J.; Severs, D.

Subjects: PREVENTION of drug side effects; BODY composition; BIOMARKERS

• Source: European Journal of Clinical Pharmacology; Aug2022, Vol. 78 Issue 8, p1273-1287, 15p, 4 Charts, 5 Graphs

Record details

Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.

• Authors : Korkor, Mai S; el-desoky, Tarek; Mosaad, Youssef M

Subjects: PHARMACOGENOMICS; GRAFT rejection; SINGLE nucleotide polymorphisms

• Source: Italian Journal of Pediatrics; 5/18/2023, Vol. 49 Issue 1, p1-13, 13p

Record details

Agricola

Record details

Tacrolimus pharmacokinetics in pediatric renal transplant patients.

• Authors : Shapiro, Ron¹

Subjects: *PHARMACOKINETICS; *PHARMACOLOGY; *IMMUNODEFICIENCY

• Source: Pediatric Transplantation. Apr2005, Vol. 9 Issue 2, p133-133. 1p.

Record details

GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism.

• Authors : Wan, Ping; Hou, Yuchen; Qiu, Bijun

Subjects: ADENOSINE triphosphate analysis; INFECTION risk factors; BODY weight

• Source: BioMed Research International; 10/30/2022, Vol. 2022, p1-15, 15p

Record details

A Comprehensive Mixed‐Method Approach to Characterize the Source of Diurnal Tacrolimus Exposure Variability in Children: Systematic Review, Meta‐analysis, and Application to an Existing Data Set.

• Authors : Leino, Abbie D.; Magee, John C.; Kershaw, David B.

Subjects: META-analysis; CONFIDENCE intervals; FOOD consumption

• Source: Journal of Clinical Pharmacology; Mar2024, Vol. 64 Issue 3, p334-344, 11p

Record details

The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients

• Authors : Li, Yi¹; Zou, Yuangao¹; Cai, Bei¹

Subjects: *INTERLEUKINS; *PROMOTERS (Genetics); *GENETIC polymorphisms

• Source: Gene. Jan2012, Vol. 491 Issue 2, p251-255. 5p.

Record details

Prediction of Drug–Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically‐Based Pharmacokinetic Modelling.

• Authors : Zhang, Hongyan; Bu, Fengjiao; Li, Lei

Subjects: DRUG interactions; TACROLIMUS; PHARMACOKINETICS

• Source: Basic & Clinical Pharmacology & Toxicology; Mar2018, Vol. 122 Issue 3, p331-340, 10p

Record details

Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation.

• Authors : Benkali, Khaled; Rostaing, Lionel; Premaud, Aurélie

Subjects: PHARMACOKINETICS; DRUG side effects; MEDICAL care

• Source: Clinical Pharmacokinetics; 2010, Vol. 49 Issue 10, p683-692, 10p, 2 Charts, 5 Graphs

Record details

Clinical Pharmacokinetics of Tacrolimus after the First Oral Administration in Renal Transplant Recipients on Triple Immunosuppressive Therapy.

• Authors : Velickovic-Radovanovic, Radmila M.; Paunovic, Goran; Mikov, Momir

Subjects: TACROLIMUS; KIDNEY transplantation; PHARMACOKINETICS

• Source: Basic & Clinical Pharmacology & Toxicology; Jun2010, Vol. 106 Issue 6, p505-510, 6p, 5 Charts, 2 Graphs

Record details